Evidence map›Paper›PMID 38300407›Full record

ArticleClinical journal of gastroenterology2024

Improvement of liver histology in hepatic sarcoidosis due to treatment with corticosteroids and ursodeoxycholic acid: a case report.

Mayuko Kikuchi, Aritoshi Koizumi, Tadashi Namisaki, Shouhei Asada, Masafumi Oyama, Fumimasa Tomooka, Yuki Fujimoto, Koh Kitagawa, Hideto Kawaratani, Hitoshi Yoshiji

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Mayuko KikuchiDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Aritoshi KoizumiDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Tadashi NamisakiDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan. tadashin@naramed-u.ac.jp.ORCID http://orcid.org/0000-0002-3158-5318
Shouhei AsadaDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Masafumi OyamaDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Fumimasa TomookaDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Yuki FujimotoDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Koh KitagawaDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Hideto KawarataniDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Hitoshi YoshijiDepartment of Gastroenterology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Nara Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a 48-year-old male with a history of pulmonary and ocular sarcoidosis. Non-caseating granulomas, identified histologically, are the most characteristic manifestation of sarcoidosis. Hepatic sarcoidosis is difficult to diagnose using radiological imaging. In the patient reported in this study, ultrasound and contrast-enhanced computed tomography scans identified multiple intra-abdominal lymphadenopathies, with evidence of liver and splenic infiltrations. The first liver biopsy revealed non-caseating granulomatous hepatitis consistent with hepatic sarcoidosis. The patient was treated with ursodeoxycholic acid (UDCA), but his laboratory parameters did not improve. Prednisone was initiated at a dose of 30 mg daily and slowly tapered. At a dose of 12.5 mg daily, marked improvements in the fibrotic and sarcoid-like lesions were noted at the second biopsy. A third biopsy was performed, with the patient on a prednisone taper of 5 mg/day showed mild fibrous expansion in the portal tracts and mild parenchymal necro-inflammatory lesions. However, overall, fibrosis marker levels remained stable over the course of treatment. A fourth biopsy was performed after a 5-year course of 5 mg/day prednisone. This revealed minimal lobular inflammation without fibrosis. Thus, treatment of this patient with corticosteroids and UDCA resulted in marked improvements in his biochemical and histological parameters.

Indexed as

Liver DiseasesSarcoidosisAdrenal Cortex HormonesFibrosisHumansMaleMiddle AgedPrednisoneUrsodeoxycholic AcidAdrenal Cortex HormonesPrednisoneUrsodeoxycholic AcidCorticosteroidsHepatic sarcoidosisLiver histology

Identifiers

PMID38300407
OpenAlexW4391449847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.